- NCT00326391
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameMethylphenidate HClProduct NameCONCERTA®Therapeutic AreaBehaviors and Mental DisordersEnrollment229% Female12%% White86%
Product ClassStimulants/ADHD/AnorexiantsSponsor Protocol Number02-159/CR011560Data PartnerJohnson & JohnsonCondition StudiedAttention Deficit Hyperactivity DisorderMean/Median Age (Years)39
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0860 : Predicting Methylphenidate Response in Adult-ADHD (A-ADHD) Using Machine Learning Approaches
- 2022-4930 : PATIENCE Individual Patient DATa Network Meta-AnalysIs of the Efficacy aNd aCceptability of ADHD mEdication
- 2020-4444 : Expectancy Effects as a Confounding Factor in ADHD Treatment Research
- 2019-3958 : Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.